Factors associated with change in 25-hydroxyvitamin d levels over longitudinal follow-up in the aric study

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 1, 2016, Pages 33-43

  McKibben, Rebeccah A ^a   Zhao, Di ^b   Lutsey, Pamela L ^c   Schneider, Andrea L C ^b   Guallar, Eliseo ^b   Mosley, Thomas H ^d   Michos, Erin D ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; VITAMIN D; 25-HYDROXYVITAMIN D;

ADULT; AGED; ARTICLE; BLACK PERSON; BODY MASS; CAUCASIAN; COHORT ANALYSIS; COMMUNITY SAMPLE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; EDUCATIONAL STATUS; FOLLOW UP; HEALTH SERVICE; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; ATHEROSCLEROSIS; BLOOD; FEMALE; MALE; MIDDLE AGED; RISK FACTOR; SEASON; UNITED STATES;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ATHEROSCLEROSIS; BODY MASS INDEX; CHOLESTEROL, HDL; DIABETES MELLITUS; EDUCATIONAL STATUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RISK FACTORS; SEASONS; SMOKING; UNITED STATES; VITAMIN D;

EID: 84954480708     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-1711     Document Type: Article

References (30)

1. Wang L, Song Y, Manson JE, et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: A meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes. 2012;5(6):819-829.
2. Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007;49(5):1063-1069.
3. Mattila C, Knekt P, Mannisto S, et al. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care. 2007;30(10):2569-2570.
4. Melamed ML, Michos ED, Post W, Astor B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168(15):1629-1637.
5. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch InternMed. 2008; 168(12):1340-1349.
6. Shoben AB, Kestenbaum B, Levin G, et al. Seasonal variation in 25-hydroxyvitamin D concentrations in the cardiovascular health study. Am J Epidemiol. 2011;174(12):1363-1372.
7. Woitge HW, Scheidt-Nave C, Kissling C, et al. Seasonal variation of biochemical indexes of bone turnover: Results of a population-based study. J Clin Endocrinol Metab. 1998;83(1):68-75.
8. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA.Serum25-hydroxyvitaminDstatus of theUSpopulation:1988-1994 compared with 2000-2004. Am J Clin Nutr. 2008;88(6):1519-1527.
9. Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med. 2009;169(6):626-632.
10. Berger C, Greene-Finestone LS, Langsetmo L, et al. Temporal trends and determinants of longitudinal change in 25-hydroxyvitamin D and parathyroid hormone levels. J Bone Miner Res. 2012;27(6):1381-1389.
11. van Schoor NM, Knol DL, Deeg DJ, Peters FP, Heijboer AC, Lips P. Longitudinal changes and seasonal variations in serum 25-hydroxyvitaminDlevels in different age groups: Results of the Longitudinal Aging Study Amsterdam. Osteoporos Int. 2014;25(5):1483-1491.
12. Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, Grimnes G. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol. 2010;171(8):903-908.
13. The Atherosclerosis Risk in Communities (ARIC) Study: Design and objectives. TheARICinvestigators.AmJ Epidemiol. 1989;129(4):687-702.
14. Mosley TH Jr, Knopman DS, Catellier DJ, et al. Cerebral MRI findings and cognitive functioning: The Atherosclerosis Risk inCommunities study. Neurology. 2005;64(12):2056-2062.
15. Lutsey PL, Eckfeldt JH, Ogagarue ER, Folsom AR, Michos ED, Gross M. The 25-hydroxyvitamin D C-3 epimer: Distribution, correlates, and reclassification of 25-hydroxyvitamin D status in the population-based Atherosclerosis Risk in Communities Study (ARIC). Clin Chim Acta. 2015;442:75-81.
16. Sachs MC, Shoben A, Levin GP, et al. Estimating mean annual 25-hydroxyvitaminDconcentrationsfromsingle measurements: The Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr. 2013;97(6):1243-1251.
17. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53-58.
18. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36(5):936-942.
19. Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20-29.
20. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1(8476):307-310.
21. Michos ED, Carson KA, Schneider AL, et al. Vitamin D and subclinical cerebrovascular disease: The Atherosclerosis Risk in Communities brain magnetic resonance imaging study. JAMA Neurol. 2014;71(7):863-871.
22. Gutierrez OM, Farwell WR, Kermah D, Taylor EN. Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos Int. 2011;22(6):1745-1753.
23. PoweCE, EvansMK,Wenger J, et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med. 2013;369(21):1991-2000.
24. SamuelL, BorrellLN.Theeffect ofbodymassindexonoptimal vitamin Dstatus in US adults: The National Health and Nutrition Examination Survey 2001-2006. Ann Epidemiol. 2013;23(7):409-414.
25. Vu LH, Whiteman DC, van der Pols JC, Kimlin MG, Neale RE. Serum vitamin D levels in office workers in a subtropical climate. Photochem Photobiol. 2011;87(3):714-720.
26. Erkal MZ, Wilde J, Bilgin Y, et al. High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: Identification of risk factors. Osteoporos Int. 2006;17(8):1133-1140.
27. Cinar N, Harmanci A, Yildiz BO, Bayraktar M. Vitamin D status and seasonal changes in plasma concentrations of 25-hydroxyvitamin D in officeworkersinAnkara,Turkey.EurJInternMed.2014;25(2):197-201.
28. Rudnicki M, Thode J, Jorgensen T, Heitmann BL, Sorensen OH. Effects of age, sex, season and diet on serum ionized calcium, parathyroid hormone and vitamin D in a random population. J Intern Med. 1993;234(2):195-200.
29. Pal BR, Marshall T, James C, Shaw NJ. Distribution analysis of vitamin D highlights differences in population subgroups: Preliminary observations from a pilot study in UK adults. J Endocrinol. 2003;179(1):119-129.
30. Dickinson A, Blatman J, El-Dash N, Franco JC. Consumer usage and reasons for using dietary supplements: Report of a series of surveys. J Am Coll Nutr. 2014;33(2):176-182.